06/10/2021
9:06 AM | Intercept Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A
| |
06/07/2021
7:15 AM | Intercept Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/02/2021
6:00 PM | Intercept Pharmaceuticals (Issuer)
Pruzanski Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/01/2021
6:03 PM | Intercept Pharmaceuticals (Issuer)
SBLENDORIO GLENN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/01/2021
6:03 PM | Intercept Pharmaceuticals (Issuer)
SANTINI GINO (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/01/2021
6:02 PM | Intercept Pharmaceuticals (Issuer)
Miller-Rich Nancy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/01/2021
6:02 PM | Gottesdiener Keith Michael (Reporting)
Intercept Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/01/2021
6:01 PM | Fundaro Paolo (Reporting)
Intercept Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/01/2021
6:01 PM | Intercept Pharmaceuticals (Issuer)
ROSA-BJORKESON DAGMAR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/01/2021
6:01 PM | BRADBURY DANIEL (Reporting)
Intercept Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
06/01/2021
6:00 PM | Benatti Luca (Reporting)
Intercept Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/01/2021
6:00 PM | AKKARAJU SRINIVAS (Reporting)
Intercept Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/26/2021
4:21 PM | Intercept Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/17/2021
6:00 PM | Intercept Pharmaceuticals (Issuer)
Richardson Linda M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2021
6:01 PM | Cawkwell Gail (Reporting)
Intercept Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/11/2021
6:00 PM | Ford David A (Reporting)
Intercept Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/06/2021
6:16 AM | Intercept Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/04/2021
6:00 PM | Intercept Pharmaceuticals (Issuer)
Pruzanski Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/15/2021
3:31 PM | Intercept Pharmaceuticals (Filer)
| Form PRE 14A
| |
04/05/2021
6:03 PM | Intercept Pharmaceuticals (Issuer)
Weyer Christian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/05/2021
6:03 PM | Intercept Pharmaceuticals (Issuer)
Venezia Rocco (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/05/2021
6:02 PM | Ford David A (Reporting)
Intercept Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/05/2021
6:02 PM | Durso Jerome Benedict (Reporting)
Intercept Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/05/2021
6:01 PM | Intercept Pharmaceuticals (Issuer)
Venezia Rocco (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/05/2021
6:00 PM | Intercept Pharmaceuticals (Issuer)
ROSA-BJORKESON DAGMAR (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/01/2021
6:00 PM | Intercept Pharmaceuticals (Issuer)
Pruzanski Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2021
6:51 PM | AKKARAJU SRINIVAS (Reporting)
Intercept Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/10/2021
7:05 AM | Intercept Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/02/2021
6:01 PM | Intercept Pharmaceuticals (Issuer)
Pruzanski Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/02/2021
6:00 PM | Intercept Pharmaceuticals (Issuer)
Weyer Christian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/25/2021
6:01 PM | Durso Jerome Benedict (Reporting)
Intercept Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/25/2021
6:15 AM | Intercept Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/22/2021
3:30 PM | Intercept Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/17/2021
6:04 PM | Intercept Pharmaceuticals (Issuer)
Richardson Linda M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/17/2021
6:01 PM | DeFrancesco Lisa (Reporting)
Intercept Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
02/17/2021
6:01 PM | Intercept Pharmaceuticals (Issuer)
Richardson Linda M (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/17/2021
6:00 PM | Cawkwell Gail (Reporting)
Intercept Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/11/2021
12:10 PM | Intercept Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G
| |
02/10/2021
6:00 PM | Ford David A (Reporting)
Intercept Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/10/2021
10:03 AM | Intercept Pharmaceuticals (Subject)
| Form SC 13G/A
| |
02/08/2021
9:25 AM | FMR LLC (Filed by)
Intercept Pharmaceuticals (Subject)
| Form SC 13G/A
| |
02/02/2021
6:00 PM | Intercept Pharmaceuticals (Issuer)
Pruzanski Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/01/2021
6:02 PM | Freedberg Jared (Reporting)
Intercept Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/01/2021
6:01 PM | Freedberg Jared (Reporting)
Intercept Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/26/2021
6:02 PM | Intercept Pharmaceuticals (Issuer)
Weyer Christian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/26/2021
6:01 PM | Intercept Pharmaceuticals (Issuer)
Kapadia Sandip (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/26/2021
6:01 PM | Ford David A (Reporting)
Intercept Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/26/2021
6:01 PM | Campagna Jason (Reporting)
Intercept Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/26/2021
6:01 PM | Durso Jerome Benedict (Reporting)
Intercept Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/26/2021
6:00 PM | Cawkwell Gail (Reporting)
Intercept Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/20/2021
3:30 PM | Intercept Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/13/2021
8:32 AM | FIRST TRUST PORTFOLIOS LP (Filed by)
Intercept Pharmaceuticals (Subject)
| Form SC 13G
| |
01/11/2021
6:01 PM | BALL BRYAN (Reporting)
Intercept Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/11/2021
6:00 PM | BALL BRYAN (Reporting)
Intercept Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/05/2021
6:01 PM | Intercept Pharmaceuticals (Issuer)
Weyer Christian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2021
6:01 PM | Intercept Pharmaceuticals (Issuer)
Pruzanski Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2021
6:01 PM | Intercept Pharmaceuticals (Issuer)
Kim Richard J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2021
6:01 PM | Intercept Pharmaceuticals (Issuer)
Kapadia Sandip (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2021
6:01 PM | Ford David A (Reporting)
Intercept Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2021
6:00 PM | Campagna Jason (Reporting)
Intercept Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2021
6:00 PM | Durso Jerome Benedict (Reporting)
Intercept Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2021
6:00 PM | Cawkwell Gail (Reporting)
Intercept Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/16/2020
6:00 PM | Intercept Pharmaceuticals (Issuer)
Kapadia Sandip (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/10/2020
7:06 AM | Intercept Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/30/2020
6:00 PM | Intercept Pharmaceuticals (Issuer)
Weyer Christian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/25/2020
6:00 PM | Durso Jerome Benedict (Reporting)
Intercept Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/16/2020
6:00 PM | Intercept Pharmaceuticals (Issuer)
Sullivan Ryan T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/16/2020
6:00 PM | Cawkwell Gail (Reporting)
Intercept Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/10/2020
6:00 PM | Ford David A (Reporting)
Intercept Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/09/2020
3:03 PM | Intercept Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/09/2020
6:15 AM | Intercept Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/09/2020
6:15 AM | Intercept Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/05/2020
6:02 PM | Campagna Jason (Reporting)
Intercept Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/05/2020
6:02 PM | Durso Jerome Benedict (Reporting)
Intercept Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/05/2020
6:02 PM | Intercept Pharmaceuticals (Issuer)
Weyer Christian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/05/2020
6:01 PM | Intercept Pharmaceuticals (Issuer)
Pruzanski Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/05/2020
6:01 PM | Intercept Pharmaceuticals (Issuer)
Kim Richard J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/05/2020
6:00 PM | Intercept Pharmaceuticals (Issuer)
Kapadia Sandip (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/05/2020
6:00 PM | Ford David A (Reporting)
Intercept Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/17/2020
6:00 PM | Campagna Jason (Reporting)
Intercept Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/01/2020
10:10 AM | Intercept Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/31/2020
6:00 PM | Intercept Pharmaceuticals (Issuer)
Weyer Christian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/31/2020
3:30 PM | Genextra S.p.A. (Filed by)
Intercept Pharmaceuticals (Subject)
| Form SC 13G/A
| |
08/25/2020
6:00 PM | Durso Jerome Benedict (Reporting)
Intercept Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2020
6:00 PM | Campagna Jason (Reporting)
Intercept Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/17/2020
7:13 PM | Genextra S.p.A. (Reporting)
Intercept Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/17/2020
7:10 PM | Intercept Pharmaceuticals (Issuer)
Micheli Francesco (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/17/2020
7:06 PM | Fundaro Paolo (Reporting)
Intercept Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2020
6:01 PM | Intercept Pharmaceuticals (Issuer)
Sullivan Ryan T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2020
6:00 PM | Cawkwell Gail (Reporting)
Intercept Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/11/2020
6:00 PM | Ford David A (Reporting)
Intercept Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/10/2020
3:04 PM | Intercept Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/10/2020
6:15 AM | Intercept Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/15/2020
4:00 PM | Intercept Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/06/2020
6:03 PM | Intercept Pharmaceuticals (Issuer)
Weyer Christian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/06/2020
6:02 PM | Intercept Pharmaceuticals (Issuer)
Pruzanski Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/06/2020
6:02 PM | Intercept Pharmaceuticals (Issuer)
Kim Richard J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/06/2020
6:01 PM | Intercept Pharmaceuticals (Issuer)
Kapadia Sandip (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/06/2020
6:01 PM | Ford David A (Reporting)
Intercept Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/06/2020
6:00 PM | Campagna Jason (Reporting)
Intercept Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
